Faughnan, Marie E.
Gossage, James R.
Chakinala, Murali M.
Oh, S. Paul
Kasthuri, Raj
Hughes, Christopher C. W.
McWilliams, Justin P.
Parambil, Joseph G.
Vozoris, Nicholas
Donaldson, Jill
Paul, Gitanjali
Berry, Pamela
Sprecher, Dennis L.
Funding for this research was provided by:
GSK
Novartis
Article History
Received: 27 March 2018
Accepted: 14 August 2018
First Online: 6 September 2018
Compliance with ethical standards
:
: MF reports grants from GSK, during the conduct of the study; personal fees from HHT Foundation International (Cure HHT), grants from NIH-NINDS-NCATS, grants from NIH-NHLBI, grants from US Department of Defense, outside the submitted work; MCM reports grants from GSK, during the conduct of the study; grants from HHT Foundation International, personal fees from Express Scripts International, outside the submitted work. JD is a GSK employee and share holder. GP reports other from Novartis, during the conduct of the study; other from GSK, outside the submitted work; PB reports other from GSK, other from Janssen Global Services, outside the submitted work. DLS reports other from GlaxoSmithKline, outside the submitted work; and I have worked with the HHT patient advocacy group for many years, but receive no monies related to that activity. However, this has motivated my interest in pursuing this work; JG, SPO, RK, CCWH, JM, JGP, NV have nothing to disclose.